Home » Business, Health & Medicine, Pharmaceuticals & Biotech, Science, UK » Alzheimer’s Disease Therapeutics & Diagnostics Market is Expected to Hit $7200 Million By 2022: Brisk Insights
BriskInsights.com has announced the addition of “Global Alzheimer’s Disease Therapeutics & Diagnostics Market By Therapeutics (Biomarkers, Cholinesterase Inhibitors, NMDA Receptor Antagonists), Diagnostics (Brain Imaging, Blood Tests), By Imaging Technologies (Structural Imaging, Molecular Imaging) , Industry Size, Growth, Share And Forecast To 2022” Market Research Report to their Database.

According to a recently published report, the global Alzheimer’s Disease Therapeutics And Diagnostics Market is expected to grow $7200 million till 2022 with the CAGR of 7.1% during 2015-2022. The segmentation of global alzheimer’s disease therapeutics and diagnostics markets is based on therapeutics, diagnostics, imaging technologies and regional outlook. The report on global alzheimer’s disease therapeutics and diagnostics market forecast 2015-2022 (therapeutics, diagnostics, imaging technologies and Regional outlook) provides detailed overview and predictive analysis of the market.

Alzheimer’s disease is a progressive, non-reversible, neurodegenerative disorder caused due to abnormal functioning of brain cells. According to National Institute of Aging, Alzheimer disease is the common form of dementia. This type of disease is mainly found in elders, 1 out of 3 senior citizens dies with alzheimer diseases or another dementia. There are various symptoms of alzheimer disease like repetitive movement, agitation, insomnia, memory loss, depression, loss of reasoning abilities and so on. This severe disease kill more peopleas compared to the lives taken by breast and prostate cancer conjointly. The global alzheimer’s disease therapeutics and diagnostics market is growing with rising prevalence of alzheimer diseases. Mainly the alzheimer’s disease is found in the people of aged 60 years or above. The working of brain is badly affected and the patient is unable to react normally as the normal human being do. The alzheimer diseases is one of the major chronic diseases that take many lives worldwide even the expenditures on the R&D of alzheimer diseases is also very high. The increasing occurrence rate and prevalence of alzheimer diseases is enhancing the global alzheimer diseases therapeutics & diagnostics market upward.

Full report is available on global alzheimer’s disease therapeutics and diagnostics market forecast 2015-2022 (therapeutics, diagnostics, imaging technologies and Regional outlook) report at http://www.briskinsights.com/report/alzheimers-disease-therapeutics-and-diagnostics-market

Scope of the report

1. Global Alzheimer’s Disease Therapeutics And Diagnostics Market By Therapeutics 2012 – 2022 ($ million)
1.1. Biomarkers
1.2. Cholinesterase inhibitors
1.3. NMDA receptor antagonists

2. Global Alzheimer’s Disease Therapeutics And Diagnostics Market By Diagnostics2012 – 2022 ($ million)
2.1. Brain imaging
2.2. Blood tests

3. Global Alzheimer’s Disease Therapeutics And Diagnostics Market By Imaging Technologies2012 – 2022 ($ million)
3.1. Structural imaging
3.2. Functional imaging
3.3. Molecular imaging

4. Global Alzheimer’s Disease Therapeutics And Diagnostics Market Regional Outlook 2012-2022( $ million)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Rest of the World

5. Company Profile
5.1. Abbvie Inc.
5.2. AC Immune SA
5.3. Allergan PLC
5.4. Amarantus Bioscience Holdings
5.5. Anavex Life Sciences
5.6. Avid Radiopharmaceuticals
5.7. Axon Neuroscience
5.8. Axovant Sciences
5.9. Daiichi Sankyo Co
5.10. Eli Lilly
5.11. F. Hoffmann La Roche AG
5.12. GE Healthcare
5.13. Janssen Pharmaceuticals
5.14. Merck & Co
5.15. Navidea Biopharmaceuticals

Full report is available onglobal alzheimer’s disease therapeutics and diagnostics market forecast 2015-2022 (therapeutics, diagnostics, imaging technologiesand Regional outlook)report at http://www.briskinsights.com/report/alzheimers-disease-therapeutics-and-diagnostics-market

About Us:

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to  aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions. Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Web: Brisk Insights

Blog:  http://www.pdfdevices.com/global-alzheimers-disease-therapeutics-and-diagnostics-market-is-expected-to-reach-7200-million-by-2022-brisk-insights/

Media Contact
Company Name: Brisk Insights
Contact Person: Jennifer Smith, Manager – Sales
Email: sales@briskinsights.com
Phone: +448081890034 (UK)
Address:Office 1094 109 Vernon House Friar Lane
City: Nottingham
Country: United Kingdom
Website: http://www.briskinsights.com/report/alzheimers-disease-therapeutics-and-diagnostics-market

Comments are closed.